Cardiovascular Care Essentials - 2026 Clinical Challenges in Hospital Medicine
-
Register
- Non-member - $150
- Member - $110
- Resident/Fellow - $40
- Student - Free!
Overview
“Cardiovascular Care Essentials” bundle brings together the four most popular Critical Care lectures from our Annual Clinical Challenges in Hospital Medicine in one convenient package:
Atrial Fibrillation 2026 - Practical Updates Every Internists Needs to Know
Speaker: Chad A. Link, DO, FACC, FACOI
CME Credits: 0.75 1A AOA
In this session, you'll learn how to:
- Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation.
- Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation.
- Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.
Financial Disclosure: Chad Link, DO, FACC, FACOI, faculty for this activity, has disclosed the following financial relationships:
• Kiniksa Pharmaceuticals: Consulting Fee - Ongoing
Updates in Stroke Prevention and Management
Speaker: Vikranth Gongidi, DO, FACOI
CME Credits: 0.75 1A AOA
In this session, you'll learn how to:
- Apply 2026 acute ischemic stroke (AIS) updates: prehospital triage, thrombolysis, and thrombectomy selection
- Implement 2021 secondary prevention strategies (antithrombotics, lipids, BP, carotids, cardioembolic sources)
- Translate 2024 primary prevention guidance into clinic workflows (Life’s Essential 8, sex-specific risk, SDOH)
Financial Disclosure: Vikranth Gongidi, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
QT Prolongation
Speaker: Robert Chilton, DO, MACOI
CME Credits: 0.25 1A AOA
In this session, you'll learn how to:
- Define the QT interval, QTc, standard normal ranges
- Identify major risk factors for TdP
- Explain the pathophysiology of QT prolongation and its link to TdP
Financial Disclosure: Robert Chilton, DO, MACOI, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Hypertrophic Cardiomyopathy: New Frontiers
Speaker: Robby Wu, DO
CME Credits: 0.75 1A AOA
In this session, you'll learn how to:
- Recognize and diagnose hypertrophic cardiomyopathy.
- Identify phenocopies of hypertrophic cardiomyopathy.
- Learn contemporary treatment strategies for hypertrophic cardiomyopathy.
Financial Disclosure: Robby Wu, DO, faculty for this activity, has disclosed the following financial relationships: • Cytokinetics: Consulting/Speaker Bureau - Ongoing
• Bristol Myers Squibb: Consulting/Speaker Bureau - OngoingType – Role – Company
CME Credit Available:
This activity offers a total of 2.50 Category 1A AOA credit
Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.
Note: ACOI reports credits to the AOA at the beginning of each month.
Pricing:
This exclusive bundle is offered at a special discounted rate, providing a 10% savings compared to purchasing each item individually.
Members: $110.00
Non-Members: $150.00
Residents/Fellows: $40.00
Students: FREE
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029. A notification will be sent 15 days prior to expiration to remind the registrant of the upcoming end date.
NOTE: This package's contents will no longer be available to access after July 31, 2029.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Recognize and diagnose hypertrophic cardiomyopathy. • Identify phenocopies of hypertrophic cardiomyopathy. • Learn contemporary treatment strategies for hypertrophic cardiomyopathy.
CME Credit Available:
This activity offers .75 1A AOA
Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Recognize and diagnose hypertrophic cardiomyopathy.
- Identify phenocopies of hypertrophic cardiomyopathy.
- Learn contemporary treatment strategies for hypertrophic cardiomyopathy.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Robby Wu, DO, faculty for this activity, has disclosed the following financial relationships: • Cytokinetics: Consulting/Speaker Bureau - Ongoing
• Bristol Myers Squibb: Consulting/Speaker Bureau - OngoingType – Role – Company
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Robby Wu, DO (he/him/his)
Advanced Heart Failure and Transplant Cardiologist
University of South Florida and Tampa General Hospital
Robby Wu, DO, is an assistant professor of medicine at the University of South Florida Morsani College of Medicine and an advanced heart failure and transplant cardiologist at Tampa General Hospital. He serves as medical director of Tampa General's Hypertrophic Cardiomyopathy Program and as associate program director of the USF Advanced Heart Failure and Transplant Cardiology fellowship.
Dr. Wu completed his undergraduate degrees in science and psychology at Pennsylvania State University and earned his medical degree at the Philadelphia College of Osteopathic Medicine in Philadelphia. He trained in internal medicine at Danbury Hospital, Yale School of Medicine, followed by a cardiovascular disease fellowship at Northside Hospital and the Tampa Bay Heart Institute and an advanced heart failure and transplant cardiology fellowship at Tampa General Hospital, USF Morsani College of Medicine. He is board certified in internal medicine, cardiovascular disease, and advanced heart failure and transplant cardiology, and is a diplomate of the National Board of Echocardiography.
His clinical and research interests span advanced heart failure, heart transplantation, mechanical circulatory support, and inherited cardiomyopathies. He serves as principal investigator on several multicenter trials, including SONATA-HCM, COMET-HF, and DRAIN-HF. His work has appeared in JACC: Heart Failure and the Journal of Heart and Lung Transplantation, and he has been invited to speak on hypertrophic cardiomyopathy, cardiogenic shock, and mechanical circulatory support at several national conferences.
Dr. Wu serves on the American College of Cardiology's Advanced Heart Failure and Transplant Cardiology Committee, chairs the USF Heart Failure Education Committee, and reviews for the Journal of Cardiac Failure. In 2025 he was named an American Heart Association Leader of Impact for Tampa Bay.
The faculty member, for this activity, has disclosed the following financial relationships:
- Cytokinetics: Consulting/Speaker Bureau – Ongoing
- Bristol Myers Squibb: Consulting/Speaker Bureau - Ongoing
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .25 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Define the QT interval, QTc, standard normal ranges • Identify major risk factors for TdP • Explain the pathophysiology of QT prolongation and its link to TdP
CME Credit Available:
This activity offers .25 1A AOA
Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Define the QT interval, QTc, standard normal ranges
- Identify major risk factors for TdP
- Explain the pathophysiology of QT prolongation and its link to TdP
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Robert Chilton, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Robert J. Chilton, DO, MACOI
Professor of Medicine
University of Texas Health Science Center
Professor of Medicine
Director of CAth Lab
Director of Clinical Protonomics
Editor in chief of Catheterization and Cardiovascular Interventions
Outstanding teacher of the year award 2024 Univ of Texas Health Science Center
The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Apply 2026 acute ischemic stroke (AIS) updates: prehospital triage, thrombolysis, and thrombectomy selection • Implement 2021 secondary prevention strategies (antithrombotics, lipids, BP, carotids, cardioembolic sources) • Translate 2024 primary prevention guidance into clinic workflows (Life’s Essential 8, sex-specific risk, SDOH)
CME Credit Available:
This activity offers .75 1A AOA
Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Apply 2026 acute ischemic stroke (AIS) updates: prehospital triage, thrombolysis, and thrombectomy selection
- Implement 2021 secondary prevention strategies (antithrombotics, lipids, BP, carotids, cardioembolic sources)
- Translate 2024 primary prevention guidance into clinic workflows (Life’s Essential 8, sex-specific risk, SDOH)
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Vikranth Gongidi, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Vikranth Gongidi, DO, FACOI
Cardiologist
Premier Cardiology of Vero Beach
The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation. • Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation. • Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.
CME Credit Available:
This activity offers .75 1A AOA
Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation.
- Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation.
- Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Chad Link, DO, FACC, FACOI, faculty for this activity, has disclosed the following financial relationships: • Kiniksa Pharmaceuticals: Consulting Fee - Ongoing
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Chad A. Link, DO, FACC, FACOI
Cardiologist
University of Michigan Health- Sparrow
Chad A. Link, D.O. FACC, FACOI received his medical degree from Michigan State University’s College of Osteopathic Medicine in East Lansing, Michigan. He completed both his Internal Medicine Residency and Cardiology Fellowship at Ingham Regional Medical Center in Lansing, Michigan. He is board certified in Internal Medicine, Cardiology and Nuclear Cardiology and serves as the cardiology chairman for the University of Michigan Health System-Sparrow Eaton and Ionia Hospitals and is a clinical assistant professor for the cardiology course at Michigan State University’s College of Osteopathic Medicine.
He specializes in cardiovascular medicine with the University of Michigan Health-Sparrow. Dr. Link’s background includes all aspects of clinical cardiology with specialized interest in the management of coronary artery disease, hyperlipidemia, echocardiography; nuclear cardiology and pulmonary hypertension. Professional memberships include: the American Society of Echocardiography, the American College of Cardiology, and the American Society of Nuclear Cardiology.The faculty member, for this activity, has disclosed the following financial relationships:
- Kiniska-Consulting Fees-Ongoing
